Key facts
- Notable investors include Tailong VC, Bangming Capital, Hangzhou Tigermed Consulting Company, Jiangsu Winfast Investment.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for PLD Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for PLD Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PLD Technology
Developer and manufacturer of biotechnology medical equipment intended to serve the cell-free protein expression technology. The company is mainly focused on the research and development of cell-free protein expression technology and various kinds of test kits products, providing clients with industry-leading standard products to use.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2017
- Employees
- 12
- Website
- cellfreeprotein.cn/
- Ownership
- Privately Held (backing)
PLD Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PLD Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PLD Technology in its N-PORT filings yet. We sweep new filings monthly.